Humana reports $7.61 adjusted EPS for Q2

• Humana reported second-quarter 2026 adjusted earnings per share of $7.61 and GAAP earnings per share of $5.73.
• The company revised its full-year 2026 GAAP EPS guidance down to at least $6.52, while maintaining its adjusted EPS forecast of at least $9.
• The healthcare provider stated it is relying on a 25% Medicare Advantage membership growth target and expansion in its primary care segment to drive volume.

Humana (NYSE:HUM) reported second-quarter 2026 adjusted earnings of $7.61 per share alongside GAAP earnings of $5.73 per share.

The company recorded an insurance segment benefit ratio of 91.2%, which matched its previous forecast of operating slightly above 91%.

Management stated it is affirming its full-year 2026 insurance segment benefit ratio expectation of 92.75%, plus or minus 25 basis points.

The business also reported year-to-date growth of 130,900 patients, representing a 27% increase, in its CenterWell Senior Primary Care division.

Executives expect full-year individual Medicare Advantage membership to grow by approximately 25% compared to 2025 levels, attributing the forecast to new sales and retention improvements.

To expand its geographic reach, the company secured a statewide Illinois Medicaid managed care contract that is scheduled to launch in January 2027.